ID
LLY icon

Integral Derivatives’s Eli Lilly LLY Stock Holding History

Integral Derivatives’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,675
Closed -$854K – 1079
2016
Q2 		$841K Buy
+10,675
New +$804K 0.02% 462
2015
Q1 		– Sell
-20,674
Closed -$1.47M – 1267
2014
Q4 		$1.43M Sell
20,674
-9,996
-33% -$675K 0.02% 552
2014
Q3 		$1.99M Buy
30,670
+12,828
+72% +$812K 0.04% 465
2014
Q2 		$1.11M Sell
17,842
-6,098
-25% -$364K 0.02% 641
2014
Q1 		$1.41M Buy
+23,940
New +$1.34M 0.03% 542

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Integral Derivatives's LLY Position: Q3 2016 in Review

Integral Derivatives sold out of Eli Lilly (LLY) in Q3 2016, closing a stake of 10,675 shares — an estimated $854K sold.

Integral Derivatives first reported a position in LLY in Q1 2014 and held it in 5 quarters. The position peaked at $1.99M in Q3 2014. 1,177 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • Integral Derivatives reported no remaining Eli Lilly position as of Q3 2016 after selling out during the quarter.
  • Integral Derivatives sold 10,675 Eli Lilly shares in Q3 2016, an estimated $854K.
  • Integral Derivatives first reported a position in Eli Lilly in Q1 2014 and held it in 5 quarters.
  • Integral Derivatives's Eli Lilly position peaked at $1.99M in Q3 2014.
  • 1,177 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Integral Derivatives's 13F filing for Q3 2016, filed 14 Nov 2016.